The bill amends the Public Health Code to regulate the sale of products containing ephedrine or pseudoephedrine. It allows individuals to offer these products for retail sale but mandates that they ensure delivery directly to the purchaser and comply with federal laws. The previous prohibition on selling these products through electronic means has been modified to allow for retail sales, provided that the seller adheres to specific regulations. Additionally, the bill introduces a new requirement for manufacturers to participate in a national, real-time logging system for tracking retail sales of these substances starting June 1, 2026.

Furthermore, the bill updates the electronic sales tracking requirements for retailers, specifying that they must submit information to the National Precursor Log Exchange (NPLEx) without incurring a fee. It also establishes that if a retailer experiences technical difficulties with the electronic system, they must maintain a written log until compliance is restored. The NPLEx is required to provide real-time access to law enforcement and generate alerts for prohibited purchases. Violations of these provisions can result in felony or misdemeanor charges, depending on the nature of the offense.

Statutes affected:
House Introduced Bill: 333.7340
As Passed by the House: 333.7340